Variant report
Variant | nsv966725 |
---|---|
Chromosome Location | chr7:86735170-86740059 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:137)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr7:86735687-86736939 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr7:86737302-86737337 | K562 | blood: | n/a | n/a |
3 | ARID3A | chr7:86740005-86740535 | K562 | blood: | n/a | n/a |
4 | ARID3A | chr7:86737613-86738710 | K562 | blood: | n/a | n/a |
5 | ATF1 | chr7:86739719-86740489 | K562 | blood: | n/a | n/a |
6 | ATF1 | chr7:86736557-86736891 | K562 | blood: | n/a | n/a |
7 | ATF3 | chr7:86740059-86740448 | K562 | blood: | n/a | n/a |
8 | BACH1 | chr7:86737972-86737973 | K562 | blood: | n/a | n/a |
9 | BHLHE40 | chr7:86740034-86740631 | K562 | blood: | n/a | n/a |
10 | BHLHE40 | chr7:86737353-86738057 | K562 | blood: | n/a | n/a |
11 | BHLHE40 | chr7:86736379-86736848 | K562 | blood: | n/a | n/a |
12 | BHLHE40 | chr7:86738291-86738459 | K562 | blood: | n/a | n/a |
13 | CBX3 | chr7:86737272-86738232 | K562 | blood: | n/a | n/a |
14 | CBX3 | chr7:86736285-86736916 | K562 | blood: | n/a | n/a |
15 | CCNT2 | chr7:86736568-86736944 | K562 | blood: | n/a | n/a |
16 | CEBPB | chr7:86737495-86738061 | K562 | blood: | n/a | chr7:86737886-86737899 |
17 | CEBPB | chr7:86736579-86736855 | K562 | blood: | n/a | n/a |
18 | CEBPB | chr7:86739881-86740523 | K562 | blood: | n/a | chr7:86740332-86740343 |
19 | CEBPB | chr7:86739937-86740548 | K562 | blood: | n/a | chr7:86740332-86740343 |
20 | CEBPB | chr7:86737824-86738025 | K562 | blood: | n/a | chr7:86737886-86737899 |
21 | CEBPB | chr7:86735313-86735509 | K562 | blood: | n/a | n/a |
22 | CEBPD | chr7:86736194-86736891 | K562 | blood: | n/a | n/a |
23 | CEBPD | chr7:86739987-86740540 | K562 | blood: | n/a | n/a |
24 | CEBPD | chr7:86740012-86740539 | K562 | blood: | n/a | n/a |
25 | CTCF | chr7:86737627-86737721 | K562 | blood: | n/a | n/a |
26 | CUX1 | chr7:86737830-86737873 | K562 | blood: | n/a | n/a |
27 | CUX1 | chr7:86736526-86737180 | K562 | blood: | n/a | n/a |
28 | EGR1 | chr7:86737718-86738115 | K562 | blood: | n/a | chr7:86737922-86737931 chr7:86737921-86737932 chr7:86737915-86737937 chr7:86737920-86737933 chr7:86737920-86737933 chr7:86737921-86737930 chr7:86737921-86737931 chr7:86737920-86737933 chr7:86737919-86737933 chr7:86737921-86737932 chr7:86737919-86737934 chr7:86737921-86737931 |
29 | EGR1 | chr7:86737323-86738135 | K562 | blood: | n/a | chr7:86737922-86737931 chr7:86737921-86737932 chr7:86737915-86737937 chr7:86737920-86737933 chr7:86737920-86737933 chr7:86737921-86737930 chr7:86737921-86737931 chr7:86737920-86737933 chr7:86737919-86737933 chr7:86737921-86737932 chr7:86737919-86737934 chr7:86737921-86737931 |
30 | EGR1 | chr7:86736522-86736868 | K562 | blood: | n/a | n/a |
31 | ELF1 | chr7:86736583-86736846 | K562 | blood: | n/a | n/a |
32 | ELK1 | chr7:86736573-86736774 | K562 | blood: | n/a | n/a |
33 | EP300 | chr7:86736451-86736909 | K562 | blood: | n/a | n/a |
34 | EP300 | chr7:86737503-86738624 | K562 | blood: | n/a | chr7:86738300-86738314 |
35 | EP300 | chr7:86735759-86735880 | K562 | blood: | n/a | n/a |
36 | EP300 | chr7:86736085-86737135 | K562 | blood: | n/a | n/a |
37 | FOS | chr7:86740049-86740547 | HUVEC | blood vessel: | n/a | chr7:86740294-86740303 chr7:86740293-86740303 chr7:86740293-86740303 chr7:86740293-86740303 chr7:86740292-86740303 chr7:86740293-86740303 |
38 | FOSL1 | chr7:86740040-86740481 | K562 | blood: | n/a | chr7:86740294-86740303 chr7:86740293-86740303 chr7:86740293-86740303 chr7:86740293-86740303 chr7:86740292-86740303 chr7:86740293-86740303 |
39 | FOXA1 | chr7:86740041-86740500 | HepG2 | liver: | n/a | n/a |
40 | FOXA1 | chr7:86740058-86740403 | HepG2 | liver: | n/a | n/a |
41 | GATA1 | chr7:86739489-86740728 | K562 | blood: | n/a | chr7:86740229-86740236 chr7:86740041-86740050 chr7:86740035-86740046 |
42 | GATA1 | chr7:86737379-86738320 | PBDE | blood: | n/a | n/a |
43 | GATA1 | chr7:86740046-86740554 | PBDE | blood: | n/a | chr7:86740229-86740236 |
44 | GATA2 | chr7:86736423-86736914 | K562 | blood: | n/a | n/a |
45 | GATA2 | chr7:86740021-86740543 | K562 | blood: | n/a | chr7:86740229-86740236 chr7:86740041-86740050 chr7:86740035-86740046 |
46 | GATA2 | chr7:86739800-86740505 | HUVEC | blood vessel: | n/a | chr7:86740229-86740236 chr7:86740041-86740050 chr7:86740035-86740046 |
47 | GATA3 | chr7:86739974-86740665 | MCF-7 | breast: | n/a | chr7:86740229-86740236 chr7:86740041-86740050 chr7:86740035-86740046 |
48 | GATA3 | chr7:86739075-86739081 | SH-SY5Y | brain: | n/a | n/a |
49 | GATA3 | chr7:86740022-86740524 | MCF-7 | breast: | n/a | chr7:86740229-86740236 chr7:86740041-86740050 chr7:86740035-86740046 |
50 | HCFC1 | chr7:86737271-86737398 | K562 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DMTF1-1 | chr7:86738855-86740598 | ENSG00000261462.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000261462 | TF binding region |
ENSG00000224046 | chromatin interactions |
ENSG00000135164 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148522485 | chr7:86735292-86735293 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs533492904 | chr7:86735315-86735316 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs2158156 | chr7:86735343-86735344 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs530962916 | chr7:86735351-86735352 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs556824022 | chr7:86735387-86735388 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs143929120 | chr7:86735435-86735436 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs369060083 | chr7:86735451-86735452 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs115366036 | chr7:86735457-86735458 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs574986244 | chr7:86735472-86735473 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs191396855 | chr7:86735474-86735475 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs10255599 | chr7:86735483-86735484 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs76053299 | chr7:86735492-86735493 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs554302330 | chr7:86735538-86735539 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs114258630 | chr7:86735602-86735603 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs572854588 | chr7:86735618-86735619 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs539378289 | chr7:86735623-86735624 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs185347844 | chr7:86735660-86735661 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs11430558 | chr7:86735686-86735687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs36074315 | chr7:86735687-86735688 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs397750040 | chr7:86735691-86735692 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs189659144 | chr7:86735697-86735698 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs183463880 | chr7:86735726-86735727 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs555114725 | chr7:86735737-86735738 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs573420907 | chr7:86735813-86735814 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs17616052 | chr7:86735831-86735832 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs552619536 | chr7:86735837-86735838 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs60108994 | chr7:86735840-86735841 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs10252463 | chr7:86735877-86735878 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs144285965 | chr7:86735878-86735879 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs564016103 | chr7:86735883-86735884 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs148674436 | chr7:86735884-86735885 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs543265457 | chr7:86735895-86735896 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs544032477 | chr7:86735903-86735904 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs377222798 | chr7:86735975-86735976 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs571490683 | chr7:86736002-86736003 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs142144066 | chr7:86736096-86736097 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs528630129 | chr7:86736097-86736098 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs547093262 | chr7:86736131-86736132 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs562702597 | chr7:86736181-86736182 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs374847313 | chr7:86736200-86736201 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs532548844 | chr7:86736243-86736244 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs201559339 | chr7:86736278-86736279 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs550655407 | chr7:86736281-86736282 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs529981209 | chr7:86736286-86736287 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs151222129 | chr7:86736291-86736292 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs80171329 | chr7:86736294-86736295 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs112105573 | chr7:86736324-86736325 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs370246743 | chr7:86736325-86736326 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs534629906 | chr7:86736347-86736348 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs554142468 | chr7:86736408-86736409 | Weak transcription Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Biliary cancer | 19435499 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:86733600-86740800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr7:86735000-86736000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr7:86735200-86736800 | Enhancers | NHDF-Ad | bronchial |
4 | chr7:86735400-86735800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr7:86735800-86736400 | Enhancers | K562 | blood |
6 | chr7:86735800-86737800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr7:86736400-86736600 | Enhancers | Primary T cells from cord blood | blood |
8 | chr7:86736400-86738200 | Flanking Active TSS | K562 | blood |
9 | chr7:86736600-86737200 | Weak transcription | Primary T cells from cord blood | blood |
10 | chr7:86736800-86737200 | Weak transcription | NHDF-Ad | bronchial |
11 | chr7:86737200-86737400 | Enhancers | NHDF-Ad | bronchial |
12 | chr7:86737200-86738200 | Enhancers | Primary T cells from cord blood | blood |
13 | chr7:86737400-86737600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr7:86737400-86740000 | Weak transcription | NHDF-Ad | bronchial |
15 | chr7:86737800-86738400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr7:86738200-86738400 | Enhancers | K562 | blood |
17 | chr7:86738400-86739800 | Weak transcription | K562 | blood |
18 | chr7:86738400-86740400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr7:86739600-86740800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr7:86739800-86742000 | Enhancers | K562 | blood |
21 | chr7:86740000-86740400 | Enhancers | NHDF-Ad | bronchial |